UNSPSC 51162336: Aspirin/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162336 Aspirin/pseudoephedrine is a Commodity code that in practice captures pharmaceutical products and medical supplies far broader than its name suggests. State and local procurement activity under this code reflects the actual purchase of parenteral products, naloxone, drug deactivation systems, and related healthcare commodities for correctional facilities, public health departments, and community health initiatives. The issuing bodies are state departments of corrections and county health agencies, which solicit these supplies through RFQ and IFB vehicles to support incarcerated populations and community opioid-response programs.

Washington State Department of Corrections and Seminole County, Florida are the two recent buyers on record. Washington DOC issued RFQ RFQQK13020 on September 8, 2026, with a due date of October 7, 2026, to procure parenteral nutrition solutions, intravenous solutions, and controlled substances across eight correctional facilities in three regions, with pricing firm through a November 26, 2026 contract start and potential awards to up to three bidders per region; the solicitation emphasizes 24-hour delivery for custom PN preparations and encourages participation from small, minority-owned, women-owned, and veteran-owned businesses under Washington's Chapter 39.19 RCW utilization goals. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, with a due date of July 26, 2023, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its community health building in Sanford, Florida. Geographic activity is concentrated in the Pacific Northwest and Southeast, though the sample size is limited.